Related Experiment Video

Updated: Sep 14, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Role of miR-26b in regulating non-small cell lung cancer progression via targeting RCN1

Xinming Chen1,2, Xiaodong Xu3, Yifan Li4

  • 1Department of Cardiovascular Surgery, The First Affiliated Hospital and Institute for Cardiovascular Science, Soochow University, Suzhou, China.

Journal of Thoracic Disease
|July 21, 2025
PubMed
Abstract

Insights

MicroRNA-26b (miR-26b) is downregulated in non-small cell lung cancer (NSCLC) due to DNA hypermethylation, inhibiting tumor suppressor activity. Restoring miR-26b suppresses NSCLC progression by targeting RCN1.

Area of Science:

  • Molecular Oncology
  • Epigenetics
  • Cancer Biology

Background:

  • Dysregulated microRNAs (miRNAs) are key drivers in non-small cell lung cancer (NSCLC) pathogenesis.
  • The tumor-suppressive role of miR-26b in NSCLC is unclear, particularly its epigenetic regulation and target interactions.
  • Understanding the miR-26b/reticulocalbin-1 (RCN1) axis is crucial for developing novel NSCLC therapies.

Purpose of the Study:

  • To elucidate the regulatory axis between miR-26b and RCN1 in NSCLC.
  • To investigate the impact of miR-26b hypermethylation on NSCLC progression.
  • To identify miR-26b as a potential therapeutic biomarker for NSCLC.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (qRT-PCR) for miR-26b expression analysis.
  • Cellular assays (MTT, colony formation, transwell) to assess NSCLC cell proliferation, migration, and invasion.
  • Methylation-specific PCR (MSP), bisulfite sequencing PCR (BSP), Western blotting, and luciferase reporter assays to confirm the miR-26b/RCN1 interaction and epigenetic regulation.

Main Results:

  • RCN1 was identified as a direct target of miR-26b, with miR-26b binding to the RCN1 3'-untranslated region (3'UTR).
  • miR-26b expression was significantly downregulated in NSCLC cells due to DNA hypermethylation.
  • Overexpression of miR-26b suppressed NSCLC cell proliferation, invasion, and migration by inhibiting RCN1.

Conclusions:

  • miR-26b functions as a tumor suppressor in NSCLC by targeting RCN1.
  • Epigenetic silencing via DNA hypermethylation contributes to miR-26b downregulation in NSCLC.
  • miR-26b holds promise as a diagnostic and therapeutic biomarker for NSCLC.
Keywords:
miR-26bnon-small cell lung cancer (NSCLC)progressionreticulocalbin-1 (RCN1)

More Related Videos

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells09:45

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells

Published on: May 21, 2019

8.5K
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

17.7K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.0K